Souhaitez-vous accéder aux communiqués récents ?

Ad-hoc-Mitteilung gemäss Art. 53 KR. Dario Eklund übergibt die leitung nach geplanter übergangsphase Pratteln, Schweiz, 23. April 2026 – Santhera Pharmaceuticals (SIX: SANN) gibt die Ernennung von...

Ad hoc announcement pursuant to Art. 53 LR. Dario Eklund to hand over leadership following planned transition Pratteln, Switzerland, April 23, 2026 – Santhera Pharmaceuticals (SIX: SANN) announces...

Sidetrade is one of the first listed AI-native company to publish the figures that connect internal agentic transformation to a margin target.

Sidetrade figure parmi les premières entreprises d’IA cotées à publier des indicateurs reliant la transformation agentique interne à un objectif de marge.

Probiotic experts Yakult appoints Shinji Yamaguchi as new MD for UK & Ireland, bringing global experience to the fast‑growing gut health category.

Stuart Milstein appointed Chief Platform Officer, bringing decades of experience in oligonucleotide drug development to underpin Aerska’s platform R&DLisa Taylor Ash joins Board of Directors,...

MinervaX Strengthens Executive Leadership Team with Two Strategic Appointments as it Advances its Maternal GBS Vaccine Towards Pivotal Trial Initiation

Stuart Milstein appointed Chief Platform Officer, bringing decades of experience in oligonucleotide drug development to underpin Aerska’s platform R&DLisa Taylor Ash joins Board of Directors,...

PannTheraPi annonce des avancées majeures dans son développement clinique et stratégique  Le dépôt du dossier réglementaire pour l’initiation de l’essai clinique de Phase 2a évaluant son candidat...

PannTheraPi files Phase 2a trial for epilepsy drug PTI5803, secures EU patent, and appoints Sophie Binay as GM & CSO.